Explainable AI for Cancer Drug Response Prediction: Beyond Univariate Feature Attributions

Explainability matters as much as accuracy in medical AI: The paper emphasizes that for cancer drug response prediction, a model's ability to provide reliable biological insights is just as important as its predictive accuracy—a critical principle for responsible AI in healthcare where clinicians need to understand why a model makes recommendations.

Current explainability methods have significant limitations: Existing approaches are computationally expensive, unreliable, and oversimplify complex biology by reducing drug response to single-gene importance scores, which could mislead researchers and clinicians about the actual mechanisms driving treatment outcomes.

Gene interactions matter more than individual genes: The paper demonstrates that cancer drug response is driven by "coordinated gene activity" rather than individual genes acting alone, meaning responsible AI systems must capture these interactions to generate scientifically valid insights rather than misleading univariate rankings.

ILLUME+ produces more stable and biologically meaningful explanations: The framework generates more robust gene importance scores than existing methods and successfully recovers known drug-gene associations and mechanisms of action, suggesting it provides more trustworthy explanations for clinical decision-making.

AI can support scientific discovery when properly designed: By enabling "AI-assisted hypothesis generation," the responsible approach to explainability described here positions machine learning as a tool to uncover novel biological mechanisms rather than simply as a black-box predictor, increasing its scientific value.